Impact of elagolix on work loss due to endometriosis-associated pain: estimates based on the results of two phase III clinical trials

Endometriosis

Achieving clinically meaningful response in endometriosis pain symptoms is associated with improvements in health-related quality of life and work productivity: Analysis of 2 phase III clinical trials

Am J Obstet Gynecol.

Pokrzywinski RM, Soliman AM, Chen J, Snabes MC, Coyne KS, Surrey ES, Taylor HS

doi: 10.1016/j.ajog.2019.11.1255.

Endometriosis

Clinically Meaningful Reduction in Dyspareunia Is Associated With Significant Improvements in Health-Related Quality of Life Among Women With Moderate to Severe Pain Associated With Endometriosis: A Pooled Analysis of Two Phase III Trials of Elagolix

J Sex Med.

Agarwal SK, Soliman AM, Pokrzywinski RM, Snabes MC, Coyne KS

doi: 10.1016/j.jsxm.2020.08.002.

Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies

Obstet Gynecol.

Surrey E, Taylor HS, Giudice L, Lessey BA, Abrao MS, Archer DF, Diamond MP, Johnson NP, Watts NB, Gallagher JC, Simon JA, Carr BR, Dmowski WP, Leyland N, Singh SS, Rechberger T, Agarwal SK, Duan WR, Schwefel B, Thomas JW, Peloso PM, Ng J, Soliman AM, Chwalisz K

doi: 10.1097/AOG.

Endometriosis

Impact of elagolix treatment on fatigue experienced by women with moderate to severe pain associated with endometriosis

Fertil Steril.

Surrey ES, Soliman AM, Agarwal SK, Snabes MC, Diamond MP

doi: 10.1016/j.fertnstert.

Endometriosis

Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial

Fertil Steril.

Donnez J, Taylor HS, Taylor RN, Akin MD, Tatarchuk TF, Wilk K, Gotteland JP, Lecomte V, Bestel E

doi: 10.1016/j.fertnstert.

Endometriosis

Efficacy and safety of ASP1707 for endometriosis-associated pelvic pain: the phase II randomized controlled TERRA study

Hum Reprod.

D'Hooghe T, Fukaya T, Osuga Y, Besuyen R, López B, Holtkamp GM, Miyazaki K, Skillern L

doi: 10.1093/humrep/dez028.

Further Publications UrologyFurther Publications Gynecology

Performance Status Restriction in Phase III Cancer Clinical Trials

J Natl Compr Canc Netw.

Abi Jaoude J, Kouzy R, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Pasalic D, Verma V, VanderWalde NA, Smith BD, Smith GL, Fuller CD, Das P, Minsky BD, Rödel C, Fokas E, Jagsi R, Thomas CR, Subbiah IM, Taniguchi CM, Ludmir EB

doi: 10.6004/jnccn.2020.7578.

Reproductive HealthEndometriosis

Oral contraceptives for pain associated with endometriosis

Cochrane Database Syst Rev.

Brown J, Crawford TJ, Datta S, Prentice A

doi: 10.1002/

Endometriosis

Health-Related Quality of Life Improvements in Patients With Endometriosis Treated With Elagolix

Obstet Gynecol.

Taylor HS, Soliman AM, Johns B, Pokrzywinski RM, Snabes M, Coyne KS

doi: 10.1097/AOG.0000000000003917.

Related content

Achieving clinically meaningful response in endometriosis pain symptoms is associated with improvements in health-related quality of life and work productivity: Analysis of 2 phase III clinical trials

Clinically Meaningful Reduction in Dyspareunia Is Associated With Significant Improvements in Health-Related Quality of Life Among Women With Moderate to Severe Pain Associated With Endometriosis: A Pooled Analysis of Two Phase III Trials of Elagolix

Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies

Impact of elagolix treatment on fatigue experienced by women with moderate to severe pain associated with endometriosis

Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial

Efficacy and safety of ASP1707 for endometriosis-associated pelvic pain: the phase II randomized controlled TERRA study

Performance Status Restriction in Phase III Cancer Clinical Trials

Oral contraceptives for pain associated with endometriosis

Health-Related Quality of Life Improvements in Patients With Endometriosis Treated With Elagolix